The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more. Post navigation Harrods Will Be Sued by Mohamed al-Fayed’s Alleged Victims, Lawyers SayGE Vernova May Cut 900 Offshore Wind Jobs as It Scales Back
